Is thalidomide effective for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia?
Pérez-Encinas
Manuel
M
Department of Hematology, Universitary Hospital of Santiago, 15706-Santiago de Compostela, Spain. manuelperez@aehh.org
Rabuñal Martínez
Maria José
MJ
Bello López
José Luis
JL
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004564:Electrocoagulation; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D006801:Humans; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy; D012008:Recurrence; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000150:complications*; D013792:Thalidomide / Q000627:therapeutic use*
D013792:Thalidomide; D008558:Melphalan